Caxton Associates (UK)’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.61M Buy
426,117
+385,215
+942% +$3.3M 0.1% 76
2025
Q4
$250K Buy
+40,902
New +$244K ﹤0.01% 658

Other funds holding PTEN

Caxton Associates (UK)'s PTEN Position: Q1 2026 in Review

Caxton Associates (UK) increased its Patterson-UTI (PTEN) stake by 942% in Q1 2026, buying an estimated $3.3M and bringing the position to 426,117 shares worth $4.61M. The position accounts for 0.1% of the portfolio, ranked #76.

Caxton Associates (UK) first reported a position in PTEN in Q4 2025 and has held it in 2 quarters since. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • Caxton Associates (UK) held 426,117 shares of Patterson-UTI worth $4.61M as of Q1 2026.
  • Caxton Associates (UK) bought 385,215 Patterson-UTI shares in Q1 2026, an estimated $3.3M.
  • Patterson-UTI made up 0.1% of Caxton Associates (UK)'s portfolio in Q1 2026, its #76 holding.
  • Caxton Associates (UK) first reported a position in Patterson-UTI in Q4 2025 and has held it in 2 quarters since.
  • 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.